Home › Soft Tissue Sarcoma › Iowa
Soft Tissue Sarcoma clinical trials in Iowa
3 studies for Soft Tissue Sarcoma are looking for participants at sites in Iowa.
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
- University of Iowa Hospitals and Clinics, Iowa City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 28, 2026 · NCT04040205Integrated Cancer Repository for Cancer Research
- Methodist Jennie Edmundson Hospital, Council Bluffs
- Covenant Medical Center, Inc, Waterloo
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699Palbociclib and Pembrolizumab in Sarcoma
- University of Iowa Hospitals & Clinics, Iowa City
RecruitingPhase 1
Ages 12 and older · All sexes · Updated May 22, 2026 · NCT06113809From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.